| Financial Year |
March 31 2023 |
| Monetary Funds |
477,663,316.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
179,871,386.43 |
| Accounts Receivable |
1,375,259,515.49 |
| Advances to Suppliers |
58,084,179.44 |
| Other Receivables |
56,690,727.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,082,899,614.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
3,457,905,782.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
907,118,386.01 |
| Under-construction Projects |
66,502,589.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
253,531,557.53 |
| R&D expenses |
-- |
| Goodwill |
2,616,529.92 |
| Long-Term Deferred and Prepaid Expenses |
1,261,145.62 |
| Deferred Income Tax Assets |
19,841,544.32 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,259,873,814.06 |
| Total Assets |
4,717,779,596.59 |
| Short-Term Loans |
871,681,100.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
576,334,716.98 |
| Accounts Payable |
1,090,279,306.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,334,214.11 |
| Taxes Payable |
7,373,644.71 |
| Interest Payable |
-- |
| Dividend Payable |
129,174,437.01 |
| Other payables |
193,077,366.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,788,127.94 |
| Other Current Liabilities |
45,750,804.24 |
| Sub-Total of Current Liabilities |
2,926,136,408.40 |
| Long-term Loans |
505,752,300.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,656,396.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
564,300,620.66 |
| Total Liabilities |
3,490,437,029.06 |
| Paid-In Capital(Or Share Stock) |
231,000,000.00 |
| Capital Surplus |
172,867,187.30 |
| Surplus Reserve |
24,559,086.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
196,893,554.33 |
| Minority Stockholder's Interest |
601,054,099.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
626,288,468.29 |
| Owner's Equity（Stockholder's Equity） |
1,227,342,567.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,717,779,596.59 |
